Controlled Drugs and Substances Act
Schedule IV
Source: Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended
24.
Zeranol (3,4,5,6,7,8,9,10,11,12-Decahydro-7,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1-one)
UK: MDA Part III Class C Section 1(e) Zeranol
PubChem: 22283; ChemSpider: 20916; Wikipedia: Zeranol
Effective 30 Jan 2003, SOR/2003-37 added:
25.
Zolpidem (N,N,6-Trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide) and any salt thereof
UK: MDA Part III Class C Section 1(a) Zolpidem
UN: Psychotropics Schedule IV Zolpidem
US: CSA Schedule IV Section c Subsection 54 Zolpidem
PubChem: 5732; ChemSpider: 5530; Bluelight: Zolpidem; Drugs Forum: Zolpidem; Erowid: Zolpidem; Wikipedia: Zolpidem
Effective 30 Jan 2003, SOR/2003-32 added:
25.1
Pemoline (2-Amino-5-phenyloxazolin-4-one) and any salt thereof
UK: MDA Part III Class C Section 1(a) Pemoline
UN: Psychotropics Schedule IV Pemoline
US: CSA Schedule IV Section f Subsection 8 Pemoline
PubChem: 4723; ChemSpider: 4561; Drugs Forum: Pemoline ; Erowid: Pemoline Synthesis; Wikipedia: Pemoline
Effective 30 Jan 2003, SOR/2003-32 added:
26.
Pyrovalerone (4ʹ-Methyl-2-(1-pyrrolidinyl)valerophenone) and any salt thereof
UK: MDA Part II Class B Section 1(aa) Pyrovalerone and Part III Class C Section 1(a) Pyrovalerone
UN: Psychotropics Schedule IV Pyrovalerone
US: CSA Schedule V Section d Subsection 1 Pyrovalerone
CA: Previously at CDSA Schedule V Section 3
PubChem: 14373; ChemSpider: 13733; Wikipedia: Pyrovalerone
Effective 31 Jul 2015, SOR/2015-209 added:
27.
Salvia divinorum (S. divinorum), its preparations and derivatives, including:
Effective 31 Jul 2015, SOR/2015-209 added:
(1)
Salvinorin A ((2S,4aR,6aR,7R,9S,10aS,10bR)-9-(Acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester)
PubChem: 128563; ChemSpider: 113947; Bluelight: Salvinorin A; Drugs Forum: Salvinorin A; Erowid: Salvia Divinorum; Wikipedia: Salvinorin A
11 March 2016 · Creative Commons BY-NC-SA ·